Pharmacists can resolve ART adherence problems to achieve HIV viral suppression
Specialty Pharmacy Times Staff
Advertisement
Articles by Specialty Pharmacy Times Staff
Some therapies approved in the United States are either fully manufactured overseas or made domestically but contain some foreign ingredients.
Secretary of Labor to consider expanding access to Association Health Plans, which could allow employers to form groups across state lines.
The Drug Quality and Security Act provides a foundation for improving the safety of drug compounding by working with outsourcing facilities to meet regulatory standards.
Top news of the week from Specialty Pharmacy Times.
Sirukumab is an anti-interleukin-6 monoclonal antibody designed to block the IL-6 pathway in a different way than currently approved IL-6 inhibitors.
Top news of the week from Specialty Pharmacy Times.
New PEPFAR strategy supports HIV/AIDS prevention efforts in more than 50 countries.
Top news of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Top articles of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Top articles of the week from Specialty Pharmacy Times.
US Preventive Services Task Force states that screening tests for ovarian cancer are often inaccurate.
The FDA is requesting a new clinical study before evaluating a new drug application for baricitinib, an oral medication for moderate-to-severe rheumatoid arthritis.
Top articles of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Top articles of the week from Specialty Pharmacy Times.
Top articles of the week from Specialty Pharmacy Times.
Top articles of the week on Specialty Pharmacy Times.
Top articles of the week on Specialty Pharmacy Times.
Top articles of the week from Specialty Pharmacy Times.
Top news of the week in oncology and cancer drug development.
Top articles of the week on Specialty Pharmacy Times.
Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.
Top articles of the week from Specialty Pharmacy Times.
Top news of the week in oncology and cancer drug development.
Advertisement
Latest Updated Articles
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential BiomarkersPublished: June 12th 2025 | Updated: June 16th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting MembersPublished: June 10th 2025 | Updated: June 12th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular CarePublished: June 2nd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment LandscapePublished: June 3rd 2025 | Updated: June 11th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201Published: May 30th 2025 | Updated: June 5th 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across BordersPublished: April 18th 2025 | Updated: April 21st 2025
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
2
Effectively Managing Immunizations in the Long-Term Care Setting
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
5
